Cancer Control in Australia: Into the 21St Century

Total Page:16

File Type:pdf, Size:1020Kb

Cancer Control in Australia: Into the 21St Century Jpn J Clin Oncol 2002;32(Supplement 1)S3–S9 Original Articles Cancer Control in Australia: Into the 21st Century Robert C. Burton Anti-Cancer Council of Victoria, Carlton, Victoria, Australia Received September 11, 2000; accepted August 13, 2001 Australia ranks highly internationally for cancer control, in part because cancer registries pro- vide comprehensive national incidence and mortality and other cancer data annually. This has facilitated short- and long-term planning over the last quarter of a century. For example, male death rates from lung cancer in Australia peaked around 1985 and are now falling steeply, whereas female rates are still rising. In women, cervical cancer incidence and mortality have fallen owing to cervical screening over the last quarter of a century. Breast cancer mortality is now trending downwards after a half-century plateau, probably because of better treatment protocols. Cancer registry based State and national population treatment surveys over the last 15 years have identified both deficiencies and strengths in evidenced-based treatment of can- cer in Australia. For example, in the State of Victoria, 5-yearly population based breast cancer treatment surveys have shown that the proportion of women who had a mastectomy versus a lumpectomy as their primary surgical operation fell from 78% in 1986 to 47% 1995. All Austral- ians are covered by a universal health care system. Therefore, socio-economic status is not a barrier to accessing high quality cancer control, whether it be prevention, screening, treatment or education. In addition, non-government organizations (NGOs) specializing in cancer control have been providing free or highly subsidized support services to patients and their families for over half a century in most states. These NGOs have also been very active in public education about cancer, especially cancer prevention. Key words: cancer – Australia – treatment – prevention – education – statistics INTRODUCTION Australia, but most of this is disability and very little is due to death. Cancer control is defined internationally as all actions which reduce the burden of cancer in the community: research, prevention, early detection, treatment, palliation, patient and CANCER INCIDENCE AND MORTALITY family support and education. Implicit is continuous monitor- National Australian data on cancer mortality has been avail- ing of population cancer outcomes: incidence, mortality, the able for over a century, based on information in medical certifi- treatments employed and the burden of cancer on the society. cates of causes of death provided to State registrars of births, What is the burden of cancer in Australia? There is a mea- deaths and marriages. State based cancer registries began to be sure developed through the World Health Organization called established over half a century ago (Victoria in 1936) to vali- Disability Adjusted Life Years or DALYs. In Australia, cancer date this death certificate data and to collect cancer treatment caused the second greatest burden of DALYs in 1996 and most and follow-up information from hospitals. Some State cancer of these DALYs were years of life lost due to premature death registries began to collect new case (incidence) data (New (1). Cardiovascular disease is the greatest cause of DALYs in South Wales from 1972) and national and State laws making Australia, but in terms of premature death, cancer is equal. It is cancer a notifiable disease came into effect in 1982. From 1982 worth noting that mental illness ranked third for DALYs in there has been universal registration of new cancer cases in Australia and an Australian Association of Cancer Registries which, together with the Australian Institute of Health and Welfare, produces an annual report: Cancer in Australia (2). For reprints and all correspondence: Robert C. Burton, Anti-Cancer Council of Victoria, 1 Rathdowne Street, Carlton, Victoria 3053, Australia. This network of State cancer registries has made it possible E-mail: [email protected] to undertake State and national population based treatment © 2002 Foundation for Promotion of Cancer Research S4 Cancer control in Australia Figure 1. The number of new cases and deaths from the 14 most common cancers (excluding non-melanocytic skin cancer) in Australia in 1996. surveys (described later) and other valuable epidemiological which was only the third commonest cause of cancer death in research, in addition to reporting cancer incidence and mortal- men in 1950, became the commonest fatal male cancer by ity. These registry data reveal that for females and males the 1960 (Fig. 2). As night follows day, so lung cancer mortality in world age standardized incidence of all cancers in Australia all populations peaks about 30 years after the peak prevalence peaked around 1995 and is now falling. These data also reveal of cigarette smoking. Australian male lung cancer mortality that male and female world age standardized cancer mortalities peaked around 1980 and 70% of adult Australian males have been falling slowly since the end of the 1980s. Australia smoked cigarettes in 1950. Stomach cancer, which was the is one of the few countries in the world where the whole popu- commonest fatal cancer in 1954, is disappearing and bowel and lation world age standardized cancer incidence and mortality prostate cancer have been on a plateau over the last half rates are both falling. century. The male melanoma mortality rate rose during the last In 1996 there were 14 potentially fatal cancers recorded in half century, plateaued in the early 1990s and is now falling. Australia, for which there were more than 1000 new cases (2). The commonest of these was colorectal cancer; however, it is worth noting that the gender specific cancers, prostate cancer in men and breast cancer in women, ranked second and third (Fig. 1). For many of these cancers, the incidence rate was twice or more the mortality rate, reflecting improvements in treatments that have occurred during the twentieth century. However, for cancers of the lung, pancreas and brain, inci- dence and mortality were almost the same, reflecting the very poor prognosis that these cancers still have. This pattern of cancer incidence and mortality is typical of westernized developed countries, where lifestyle factors such as cigarette smoking and consumption of diets high in calories and fats and low in vegetables are common. TRENDS IN CANCER MORTALITY RATES IN AUSTRALIA Between 1990 and 1996 the world age standardized cancer mortality rates in Australia for both males and females fell by 0.4% per year (2). Mortality trends for the five commonest potentially fatal cancers in Australia, together with stomach and cervical cancers, are considered below. Cancer mortality Figure 2. Mortality trends of five common cancers in Australian men, 1950– trends in men over the last half century reveal that lung cancer, 1995. Jpn J Clin Oncol 2002;32(Supplement 1) S5 GOVERNMENT FUNDING OF CANCER CONTROL IN AUSTRALIA The Commonwealth (National or Federal) Government has the major responsibility for funding health in Australia and in respect of cancer there are three major mechanisms. Cancer research is funded via the National Health and Medical Research Council (NHMRC). In 1995 an NHMRC National Breast Cancer Centre was created to improve breast cancer management in Australia. In 1996 government funding from all sources for cancer research was about 71 million dollars (Australian dollars are quoted throughout). There is now a National Cancer Control Initiative, the counterpart of the National Cancer Institutes in other countries, which was estab- lished in 1997 to advise the Commonwealth Government about cancer policy, to produce and facilitate the implementation of a national cancer control plan and to develop and manage cancer control projects. A major mechanism for Commonwealth Government fund- ing of health care is via funding grants to the eight State and Territory governments, all of which have health departments. Figure 3. Mortality trends of six common cancers in Australian women, 1950– 1995. There is an Australian Health Ministers Advisory Council, where the Commonwealth and State Health Ministers meet to coordinate their respective government activities in health For women, the commonest potentially fatal cancer is breast care. In respect of cancer most of these funding grants are cancer and it has been on a plateau of mortality for most of the expended on the diagnosis, treatment and palliation of cancer twentieth century (Fig. 3). Mortality from breast cancer is now in public (government) hospitals. In addition, there are the two falling in Australia as of 1995 and this is probably attributable national cancer screening programmes mentioned above and in to adjuvant chemotherapy and hormone drug treatment. The the 2000 Commonwealth Budget a feasibility study on colo- national mammographic screening programme is not expected rectal cancer screening was funded. These National Cancer to have an effect until later this decade. Bowel cancer is screening programmes are largely implemented by the State becoming less fatal in women. In the first half of the twentieth and Territory governments, using Commonwealth funding. century Australian men and women had almost the same bowel The third major mechanism of Commonwealth Government funding is via direct payments to health care professionals on a cancer fatality rates. The fall in the women’s rate, but not in the fee for service basis and via subsidization of the pharmaceuti- men’s, has been attributed to a number of factors. A likely cal drugs which they prescribe. This effectively provides free cause is the introduction of synthetic oestrogens to the treat- primary health care to all Australians via primary health care ment of women beginning in the 1950s and 1960s, in the form physicians (General Practitioners), who can refer patients to of hormone replacement therapy and the contraceptive pill. appropriately qualified specialist medical practitioners. For Stomach cancer is disappearing in women as it is in men and cancer, these are medical practitioners who have specialist for the same reasons.
Recommended publications
  • Is the Risk of Cancer in Australia Overstated? the Importance of Competing Mortality for Estimating Lifetime Risk
    Research Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk Anthea C Bach1,2,* , Kelvin SE Lo2,3,*, Thanya Pathirana4,5, Paul P Glasziou5 , Alexandra L Barratt6, Mark A Jones5,7, Katy JL Bell6 Abstract The known: The Australian Institute of Health and Welfare (AIHW), like many cancer registries, calculates cumulative risk Objectives: To calculate lifetime risks of cancer diagnosis and from cross- sectional data to estimate lifetime risks of cancer cancer- specific death, adjusted for competing mortality, and to diagnosis and mortality. Its method assumes there are no compare these estimates with the corresponding risks published by competing causes of death, which may lead to overestimation of the Australian Institute of Health and Welfare (AIHW). lifetime risk. Design, setting: Analysis of publicly available annual AIHW data The new: Adjusting for competing mortality reduced the on age- specific cancer incidence and mortality — for breast cancer, estimated lifetime risks of cancer diagnosis and cancer- specific colorectal cancer, prostate cancer, melanoma of the skin, and lung mortality for the five most common cancers in Australia. cancer — and all- cause mortality in Australia, 1982–2013. The implication: Estimates of cancer- specific risk are widely Outcome measures: Lifetime risks of cancer diagnosis and circulated in awareness campaigns and for promoting early mortality (to age 85), adjusted for competing mortality. detection activities. Adjusted estimates would be more appropriate Results: During 1982–2013, AIHW estimates were consistently for informing choices by individuals. higher than our competing mortality- adjusted estimates of lifetime risks of diagnosis and death for all five cancers.
    [Show full text]
  • Lung Cancer Screening Enquiry – Consultation Paper
    Lung Cancer Screening enquiry – consultation paper On 1 August 2019, the Minister for Health, the Hon. Greg Hunt MP, invited Cancer Australia to conduct an enquiry into the prospects, process and delivery of a national lung cancer screening program for people at high risk of lung cancer in Australia. Cancer Australia is seeking input and submissions from all Australians with an interest in lung cancer to help inform the enquiry. Consultation paper This consultation paper is for stakeholders who wish to provide input to the Lung Cancer Screening enquiry (the enquiry) through the Lung Cancer Screening enquiry Consultation Hub. It includes information about why the enquiry is being held, describes the policy context and provides an overview of the proposed approach to the enquiry and the issues under consideration in design of a possible national lung cancer screening program for Australia. Why is the enquiry being held? The enquiry is being held to investigate the feasibility of a national lung cancer screening program for people at high risk of lung cancer in Australia. Cancer Australia will submit a report to the Minister for Health on the prospects, process and delivery of such a program. The enquiry recognises the need for continuing effort to reduce deaths from lung cancer in Australia. Lung Lung cancer in Australia cancer is a common cancer in Australian men and • In 2019, 12,817 people are women and the leading cause of cancer-related estimated to be diagnosed with deaths in Australia. lung cancer in Australia (8.9% of all new cancer cases) More than half of all cases of lung cancer are • In 2019, 9,034 people are diagnosed at an advanced stage, when the likelihood estimated to die from lung of effective treatment is lower.
    [Show full text]
  • Lung Cancer in Queensland, 1982 to 2004
    Current status of lung cancer in Queensland, 1982 to 2004 December 2007 Viertel Centre for Research in Cancer Control Accredited by the NHMRC as an independent research institute The generosity of the Queensland community and the Sylvia and Charles Viertel Charitable Foundation makes our research possible We are an independent, community-based charity and are not government funded Current status of lung cancer in Queensland, 1982 to 2004 The Cancer Council Queensland Current status of lung cancer in Queensland, 1982 to 2004 December 2007 Viertel Centre for Research in Cancer Control The Cancer Council Queensland Current status of lung cancer in Queensland, 1982 to 2004 The Cancer Council Queensland Viertel Centre for Research in Cancer Control Executive Summary The Cancer Council Queensland 553 Gregory Terrace The Cancer Council Queensland is dedicated to eliminating cancer and diminishing suffering from Fortitude Valley QUEENSLAND 4006 cancer through research, treatment, patient care and prevention and early detection.1 Part of this AUSTRALIA commitment includes informing Queenslanders of the latest available data on cancer. Postal Address: This report is the second in a series (following an earlier publication on prostate cancer),2 and PO Box 201 contains a comprehensive description of lung cancer incidence, mortality, survival and prevalence Spring Hill QUEENSLAND 4004 in Queensland utilising the most recent information released by the Queensland Cancer Registry. AUSTRALIA Comparisons are also made against Australian and international results where applicable. Telephone: +61 7 3258 2309 Comment boxes appear throughout the report. These comments have been included to expand Facsimile: +61 7 3258 2310 on the statistical information that has been presented and to provide more detailed information on Email: [email protected] recently published research into lung cancer epidemiology and the effects of smoking.
    [Show full text]
  • Enquiry Report on the Lung Cancer Screening Enquiry Report on the Lung Cancer Screening Enquiry
    REPORT ON THE LUNG CANCER SCREENING ENQUIRY REPORT ON THE LUNG CANCER SCREENING ENQUIRY REPORT ON THE LUNG CANCER SCREENING ENQUIRY Report on the Lung Cancer Screening Enquiry was prepared and produced by: Cancer Australia Locked Bag 3 Strawberry Hills NSW 2012 Australia Freecall 1800 624 973 +61 2 9357 9400 canceraustralia.gov.au © Cancer Australia 2020. ISBN Print: 978-1-74127-355-7 ISBN Online: 978-1-74127-356-4 Recommended citation Cancer Australia, 2020. Report on the Lung Cancer Screening Enquiry, Cancer Australia, Surry Hills, NSW. Copyright statements Paper-based publications This work is copyright. You may reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction. Apart from rights to use as permitted by the Copyright Act 1968 or allowed by this copyright notice, all other rights are reserved and you are not allowed to reproduce the whole or any part of this work in any way (electronic or otherwise) without first being given the specific written permission from Cancer Australia to do so. Requests and inquiries concerning reproduction and rights are to be sent to the Publications and Copyright contact officer, Cancer Australia, Locked Bag 3, Strawberry Hills, NSW 2012. Internet sites This work is copyright. You may download, display, print and reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction.
    [Show full text]
  • Cancer in Australia 2000 (Full Publication) (AIHW)
    Cancer in Australia 2000 The Australian Institute of Health and Welfare is Australia’s national health and welfare statistics and information agency. The Institute’s mission is Better health and wellbeing for Australians through better health and welfare statistics and information. The Australasian Association of Cancer Registries (AACR) is a collaborative body representing state and territory cancer registries in Australia and New Zealand. Most are members of the International Association of Cancer Registries. The AACR was formed in November 1982 to provide a formal mechanism for promoting uniformity of collection, classification and collation of cancer data. The purposes of the AACR are: S to provide a continuing framework for the development of population-based cancer registration in Australia and New Zealand; S to facilitate the exchange of scientific and technical information between cancer registries and to promote standardisation in the collection and classification of cancer data; S to facilitate cancer research both nationally and internationally; and S to facilitate the dissemination of cancer information. The Australian Institute of Health and Welfare has joined with the AACR to produce national cancer statistics from the National Cancer Statistics Clearing House. CANCER SERIES Number 23 Cancer in Australia 2000 November 2003 Australian Institute of Health and Welfare Australasian Association of Cancer Registries Canberra AIHW cat. no. CAN 18 © Australian Institute of Health and Welfare 2003 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced without prior written permission from the Australian Institute of Health and Welfare. Requests and enquiries concerning reproduction and rights should be directed to the Head, Media and Publishing Unit, Australian Institute of Health and Welfare, GPO Box 570, Canberra ACT 2601.
    [Show full text]
  • Report on Lung Cancer in Australia Literature Review and Consultation
    REPORT ON LUNG CANCER IN AUSTRALIA LITERATURE REVIEW AND CONSULTATION ON FACTORS IMPACTING ON LUNG CANCER OUTCOMES This project is an initiative of Cancer Australia’s National Lung Cancer Program funded by the Australian Government. The report was prepared by Curtin University. Report on Lung Cancer in Australia. Literature review and consultation on factors impacting on lung cancer outcomes ISBN: 978-1-74241-375-4 Online ISBN: 978-1-74241-376-1 Publications Number: D0161 Copyright Statements: Paper-based publications © Commonwealth of Australia 2011 This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part may be reproduced by any process without prior written permission from the Commonwealth. Requests and inquiries concerning reproduction and rights should be addressed to the Commonwealth Copyright Administration, Attorney-General’s Department, Robert Garran Offices, National Circuit, Barton ACT 2600 or posted at http://www.ag.gov.au/cca Internet sites © Commonwealth of Australia 2011 This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. Apart from any use as permitted under the Copyright Act 1968, all other rights are reserved. Requests and inquiries concerning reproduction and rights should be addressed to Commonwealth Copyright Administration, Attorney-General’s Department, Robert Garran Offices, National Circuit, Barton ACT 2600 or posted at http://www.ag.gov.au/cca
    [Show full text]
  • Risk Factors for Lung Cancer
    Risk factors for lung cancer An overview of the evidence 2014 Risk factors for lung cancer: an overview of the evidence was prepared and produced by: Cancer Australia Locked Bag 3 Strawberry Hills NSW 2012 Australia Tel: +61 2 9357 9400 Fax: +61 2 9357 9477 canceraustralia.gov.au © Cancer Australia 2014. Published with minor amendments. ISBN Print: 978-1-74127-269-7 ISBN Online: 978-1-74127-262-8 Recommended citation Cancer Australia, 2014. Risk factors for lung cancer: an overview of the evidence, Cancer Australia, Surry Hills, NSW. Risk factors for lung cancer: an overview of the evidence can be downloaded from the Cancer Australia website: canceraustralia.gov.au or ordered by telephone: 1800 624 973. Copyright statements Paper-based publications This work is copyright. You may reproduce the whole or part of this work in unaltered form for your own personal use or, if you are part of an organisation, for internal use within your organisation, but only if you or your organisation do not use the reproduction for any commercial purpose and retain this copyright notice and all disclaimer notices as part of that reproduction. Apart from rights to use as permitted by the Copyright Act 1968 or allowed by this copyright notice, all other rights are reserved and you are not allowed to reproduce the whole or any part of this work in any way (electronic or otherwise) without first being given the specific written permission from Cancer Australia to do so. Requests and inquiries concerning reproduction and rights are to be sent to the Publications and Copyright contact officer, Cancer Australia, Locked Bag 3, Strawberry Hills, NSW 2012.
    [Show full text]
  • Lung Cancer Australian Study PEEK Volume 1 Issue 8, January 2019
    2018 TIONS TA TIENT KNOWLEDGE PA EXPEC EXPERIENCE PEwww.cc-dr.orgE K Lung cancer Australian Study PEEK Volume 1 Issue 8, January 2019 1 This study was generously sponsored by AstraZeneca Australia. AstraZeneca provided arm’s length sponsorship for the Centre for Community-Driven Research to implement the PEEK protocol in bladder cancer. The sponsor had no input into the methodology, data collection, data analysis of reporting. The International Centre for Community-Driven Research team for this study included: Catherine Holliday Anne Holliday Josephine Byrne Hunter Baggen Vanessa Brunelli Jill Wilson Katriona Smith Daniel Martino-Burke CCDR would like to thank each and every person that participated in this PEEK study. A special thank you also to our study partners Love and Light Support Group, Changing Lung Cancer, Love our Lungs and Lung Foundation Australia. We dedicate this PEEK study in lung cancer to Belinda Jones and Jay Silva. 2 Contents Summary of Results 4 Section 1: Introduction and methodology 29 Section 2: Demographics 38 Section 3: Symptoms and diagnosis 85 Section 4: Decision-making 111 Section 5: Treatment 126 Section 6: Communication and information 171 Section 7: Care and support 221 Section 8: Quality of life and experience in the health system 248 Section 9: Expectations and Messages 275 Section 10: Advice 300 Section 11: Discussion 307 Section 12: What’s next? 322 3 Summary Summary Lung Cancer 2018 Australian PEEK Study Summary Executive summary Characterisation of this study population: In this PEEK study, more women than men participated. There was an even number of participants with a high school or trade education compared with a university education and at ratio of 5:3 in relation to participants from a higher socioeconomic group compared to a lower socio-economic group.
    [Show full text]
  • Lung Cancer in Queensland an Overview 2012
    Lung Cancer in Queensland An Overview 2012 Acknowledgements The authors acknowledge and appreciate the work of Queensland Health staff who contribute to and participate in the development and maintenance of Queensland Oncology Repository, Queensland Oncology Online and the Oncology Analysis System which supports the collection, analysis and interpretation of cancer information in Queensland. The report was prepared by Michael Blake, Shoni Colquist, Danica Cossio, Tracey Guan, Hazel Harden and Dannie Zarate. We also wish to thank Associate Professor Rayleen Bowman and Professor Kwun Fong for reviewing the report and providing valuable comments. For more information: Queensland Cancer Control Analysis Team Queensland Health GPO Box 48 Brisbane, Queensland, 4001 Australia Ph: +61 (07) 3239 0886 Fax: +61 (07) 3239 0930 Email: [email protected] https://qccat.health.qld.gov.au Lung Cancer in Queensland: An Overview 2012 Suggested citation: Queensland Government. Lung Cancer in Queensland: An overview 2012. Queensland Health, Brisbane, 2012 Copyright protects this publication. However, the Queensland Government has no objection to this material being reproduced with acknowledgement, except for commercial purposes. Permission to reproduce for commercial purposes should be sought from: The Manager Queensland Cancer Control Analysis Team Queensland Health GPO Box 48 Brisbane, Queensland, 4001 Australia ISBN: 978-1-921707-91-9 Published by Queensland Health November 2012 ©The State of Queensland, Queensland Health 2012 Table of Contents Foreword..............................................................................................................................................................................
    [Show full text]
  • The Association Between Air Pollution and Lung Cancer in the North West of Adelaide
    The association between air pollution and lung cancer in the North West of Adelaide: a case control study and air quality monitoring Melissa Jayne Whitrow Department of Medicine and Department of Public Health Faculty of Health Science The University of Adelaide July 2004 Table of Contents 1. Chapter 1 Introduction..............................................................................................25 1.1. Lung Cancer...........................................................................................................29 1.1.1. Lung Cancer Demographics...........................................................................29 1.1.2. Lung Cancer in Australia...............................................................................33 1.1.3. Aetiology........................................................................................................37 1.2. North Western Metropolitan Adelaide................................................................38 1.2.1. Lung Cancer in the North West......................................................................40 1.2.2. Industry in the North West.............................................................................40 1.2.3. Ambient Air Quality in the NW.....................................................................49 2. Chapter 2 Review of the Literature..........................................................................51 2.1. Lung Cancer Histology..........................................................................................52 2.1.1.
    [Show full text]
  • Lung Cancer Screening Feasibility In'australia
    Luton, UK. 6Basildon and Thurrock University Hospitals NHS Foundation Trust, Basildon, UK. 7Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust, King’s Lynn, UK. 8James Paget University Hospitals NHS Foundation Trust, Great Yarmouth, UK. 9Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough, UK. 10West Suffolk Hospitals NHS Foundation Trust, Bury St Edmunds, UK. 11Mid Essex Hospital Services NHS Trust, Chelmsford, UK. 12MRC Biostatistics Unit, Institute of Public Health, University of Cambridge, Cambridge, UK. 13These authors contributed equally. Correspondence: Stefan J. Marciniak, Cambridge Institute for Medical Research, Hills Road, Cambridge CB2 0XY, UK. E-mail: [email protected] Received: June 27 2014 | Accepted after revision: Feb 03 2015 | First published online: March 18 2015 Support statement: The study was funded by the East Anglian Thoracic Society. M.Z. Nikolić is a Wellcome Trust PhD Programme for Clinicians Fellow at the University of Cambridge. S.J. Marciniak is a Medical Research Council Senior Clinical Fellow. J. Wason is funded by the Cambridge Biomedical Research Centre. Funding information for this article has been deposited with FundRef. Conflict of interest: None declared. References 1 Gupta D, Hansell A, Nichols T, et al. Epidemiology of pneumothorax in England. Thorax 2000; 55: 666–671. 2 Baumann MH, Strange C, Heffner JE, et al. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest 2001; 119: 590–602. 3 MacDuff A, Arnold A, Harvey J, et al. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65: Suppl. 2, ii18–ii31. 4 Kelly AM, Druda D. Comparison of size classification of primary spontaneous pneumothorax by three international guidelines: a case for international consensus? Respir Med 2008; 102: 1830–1832.
    [Show full text]
  • National Asbestos Profile for Australia NOVEMBER 2017
    National Asbestos Profile for Australia NOVEMBER 2017 Asbestos Safety and Eradication Agency Report – 11-2017 This report has been prepared by the Asbestos Safety and Eradication Agency. The Asbestos Safety and Eradication Agency (ASEA) would like to acknowledge the contributions of members of its Technical Research Advisory Committee, Julia Collins, Professor and Director Ken Takahashi of the Asbestos Diseases Research Institute (ADRI), Safe Work Australia, Department of Immigration and Border Protection (DIBP), the enHealth Committee, iCare Dust Diseases Care (NSW) and state and territory work health and safety (WHS) regulatory bodies. 2 Contents Introduction 6 1. Current regulations on the different forms of asbestos 8 2. Import and consumption of asbestos each year 14 3. Importation of goods containing asbestos 17 4. Domestic production of asbestos 20 5. Domestic production of asbestos-containing materials 22 6. Estimated total number of workers exposed to asbestos in Australia 23 7. Industries where exposure to asbestos is present in Australia those with the largest numbers of workers potentially exposed to asbestos 25 8. Industries exceeding occupational exposure limits and estimated total number of workers at high risk 27 9. Estimate of the burden of asbestos-related diseases: disability adjusted life years and deaths attributable to asbestos exposure 29 10. Prevalence of asbestosis 32 11. Incidence of lung cancer among workers exposed to asbestos 34 12. Incidence of mesothelioma 35 13. Estimates on the percentage of house stock and vehicle fleet containing asbestos 37 14 Total number of workers eligible for compensation for asbestos-related diseases per year and the numbers of individuals compensated yearly 40 15.
    [Show full text]